LAURIE FASHAKIN: Open Payments
NPI 1275588063 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 40 payments from 12 companies in 2025. Trend: 2023 $2,522 · 2024 $1,487 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $215 |
| ABBVIE INC. | 12 | $158 |
| LEO Pharma Inc. | 4 | $118 |
| PFIZER INC. | 4 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Amgen Inc. | 3 | $69 |
| GENZYME CORPORATION | 2 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
| Almirall LLC | 2 | $35 |
| Journey Medical Corporation | 1 | $24 |
Products named: TREMFYA, ADBRY, SKYRIZI, CIBINQO, Otezla, DUPIXENT, COSENTYX, RINVOQ.
Industry payments across FL — which companies pay providers there.
